Target Name: Geranylgeranyl transferase
NCBI ID: P16432
Review Report on Geranylgeranyl transferase Target / Biomarker Content of Review Report on Geranylgeranyl transferase Target / Biomarker
Geranylgeranyl transferase
Other Name(s): Protein geranylgeranyltransferase | GGTase | Geranylgeranyltransferase

Geranylgeranyl Transferase: Potential Drug Target Or Biomarker

Geranylgeranyl transferase (nonspecified subtype), also known as protein geranylgeranyltransferase, is a protein that plays a crucial role in the metabolism of ginger and other plants that contain terpenoids, which are natural compounds that exhibit a wide range of pharmacological and biological activities. This enzyme is involved in the transfer of the geranyl group from a substrate protein to another protein, which is essential for the production of various terpenoids.

The geranyl group is a aromatic side chain that is commonly found in terpenoids and is known for its anti-inflammatory and analgesic properties. The geranylgeranyltransferase enzyme is responsible for converting the geranyl group from a substrate protein to another protein, which is known as the target protein. This conversion process is critical for the production of various terpenoids, which are involved in various physiological processes in the body, including pain relief, inflammation, and cellular signaling.

One of the unique features of geranylgeranyltransferase is its versatility in the production of different terpenoids. This enzyme can convert various substrate proteins to produce different terpenoids, making it a potential drug target or biomarker. For example, the compound curcumin, which is the major active ingredient in turmeric, is an important terpenoid that has been shown to have anti-inflammatory and analgesic properties. The geranylgeranyltransferase enzyme is involved in the production of curcumin from its substrate protein, which makes it an attractive target for drug development.

In addition to its potential as a drug target, geranylgeranyltransferase is also a potential biomarker for various diseases. For example, the levels of geranylgeranyltransferase have been shown to be elevated in individuals with rheumatoid arthritis, which is an autoimmune disorder that causes joint inflammation and pain . This suggests that geranylgeranyltransferase may be a useful biomarker for the diagnosis and treatment of rheumatoid arthritis.

Another potential application of geranylgeranyltransferase is its use as a dietary supplement. The geranyl group is known for its anti-inflammatory and analgesic properties, making it a potential ingredient in dietary supplements for the relief of joint pain and inflammation. However, more research is needed to determine the optimal dosage and method of delivery for the use of geranylgeranyltransferase as a dietary supplement.

In conclusion, geranylgeranyltransferase is a versatile enzyme that plays a critical role in the production of various terpenoids, which are involved in various physiological processes in the body. Its potential as a drug target or biomarker makes it an attractive target for further research, while its potential as a dietary supplement has also been of interest. Further studies are needed to fully understand its role and potential applications in the healthcare field.

Protein Name: Geranylgeranyl Transferase (nonspecified Subtype)

The "Geranylgeranyl transferase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Geranylgeranyl transferase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Geranylgeranyl transferase type-1 | GET1 | GET3 | GET4 | GFAP | GFER | GFI1 | GFI1B | GFM1 | GFM2 | GFOD1 | GFOD2 | GFPT1 | GFPT2 | GFRA1 | GFRA2 | GFRA3 | GFRA4 | GFRAL | GFUS | GGA1 | GGA2 | GGA3 | GGACT | GGCT | GGCX | GGH | GGN | GGNBP1 | GGNBP2 | GGPS1 | GGT1 | GGT2P | GGT3P | GGT5 | GGT6 | GGT7 | GGT8P | GGTA1 | GGTLC1 | GGTLC2 | GGTLC3 | GH1 | GH2 | GHDC | GHITM | GHR | GHRH | GHRHR | GHRL | GHRLOS | GHSR | GID4 | GID8 | GIGYF1 | GIGYF2 | GIHCG | GIMAP1 | GIMAP1-GIMAP5 | GIMAP2 | GIMAP3P | GIMAP4 | GIMAP5 | GIMAP6 | GIMAP7 | GIMAP8 | GIMD1 | GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3